Mazenot C, Durand A, Ribuot C, Demenge P, Godin-Ribuot D
Laboratoire de Pharmacologie Cardiovasculaire Expérimentale-Biomolécules, Université Joseph Fourier, Grenoble, France.
Fundam Clin Pharmacol. 1999;13(4):455-60. doi: 10.1111/j.1472-8206.1999.tb00003.x.
The aim of this study was to evaluate the ability of H3-histaminergic prejunctional receptors to modulate the noradrenaline release induced by myocardial ischaemia in the rat, and the effects of an eventual modulation on haemodynamic, biochemical and electrophysiological parameters. Isolated rat hearts were perfused according to the Langendorff technique. Control hearts (n = 13) were not treated; two groups were treated with the H3-agonist R-alpha-methyl-histamine at 0.3 microM (n = 14) and 1 microM (n = 11) and one group, used as positive control, was treated with the selective alpha 2-agonist Mivazerol at 0.5 microM (n = 14) added to the perfusion medium. Noradrenaline, lactate and transaminase output in the coronary effluent, as well as various haemodynamic and electrophysiological parameters, were measured during global and total ischaemia (30 min) and reperfusion (30 min). alpha 2-receptor stimulation increased ischaemia-induced noradrenaline release during reperfusion (195 +/- 13 vs. 145 +/- 12 pmol.g-1 in control group, P < 0.05). In contrast, R-alpha-methyl-histamine, at both doses, did not significantly modify these parameters. Both treatments did not affect ischaemia- and reperfusion-induced haemodynamic (decrease in heart rate or in left ventricular developed pressure), biochemical (lactate and GOT release) and electrophysiological (arrhythmias or increase in action potential duration) alterations. Unlike other species, the rat appears to be insensitive to H3-histaminergic receptor modulation of ischaemia-induced noradrenaline release, although a modulation can be seen with other prejunctional receptor agonists.
本研究旨在评估H3组胺能节前受体调节大鼠心肌缺血诱导的去甲肾上腺素释放的能力,以及最终调节对血流动力学、生化和电生理参数的影响。采用Langendorff技术灌注离体大鼠心脏。对照组心脏(n = 13)未进行处理;两组分别用0.3微摩尔/升(n = 14)和1微摩尔/升(n = 11)的H3激动剂R-α-甲基组胺处理,一组作为阳性对照,用添加到灌注液中的0.5微摩尔/升的选择性α2激动剂米伐唑醇处理(n = 14)。在全心缺血(30分钟)和再灌注(30分钟)期间,测量冠脉流出液中的去甲肾上腺素、乳酸和转氨酶输出量,以及各种血流动力学和电生理参数。α2受体刺激增加了再灌注期间缺血诱导的去甲肾上腺素释放(对照组为145±12皮摩尔·克-1,α2受体刺激组为195±13皮摩尔·克-1,P < 0.05)。相比之下,两种剂量的R-α-甲基组胺均未显著改变这些参数。两种处理均未影响缺血和再灌注诱导的血流动力学(心率或左心室舒张末压降低)、生化(乳酸和谷草转氨酶释放)和电生理(心律失常或动作电位时程增加)改变。与其他物种不同,大鼠似乎对缺血诱导的去甲肾上腺素释放的H3组胺能受体调节不敏感,尽管其他节前受体激动剂可观察到调节作用。